Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5024048 (Mericitabine) plus Pegasys and Copegus in Chronic Hepatitis C
NCT01057667Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of mericitabine in hepatitis C (HCV), sponsored by Roche. Started Feb 2010; status: completed.
02
Drugs
mericitabine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01057667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057667.